In this study, we construct a prognosis risk model to predict the overall survival (OS) outcomes of NSCLC patients based on the expression of five hub ANKRD genes (ANKRD29, ANKRD34B, ANKRD40CL, ANKRD44 and ANKRD66). The gene discussed is ANKRD34B; the disease is non-small cell lung carcinoma.